COVID-19 and Vasa vasorum: New Atherogenic Factor? A Case Report and Autopsy Findings

Julia A Macarova1, Sofia A Malakhova1, Tatiana A Novitskaya1,2

  • 1Laboratory of the Microangiopathic Mechanisms of Atherogenesis, Saint Petersburg State University, 199034 Saint-Petersburg, Russia.

Insights

COVID-19 patients face increased cardiovascular risks, potentially due to SARS-CoV-2 affecting blood vessels. This study links viral infection to atherosclerosis and stroke via Vasa vasorum inflammation.

Area of Science:

  • Cardiovascular Pathology
  • Infectious Disease
  • Vascular Biology

Background:

  • COVID-19 is associated with elevated cardiovascular complications, including thrombosis and thromboembolism.
  • The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) may destabilize atherosclerotic plaques.
  • Viral infection can progressively alter blood vessels, impacting cardiovascular health.

Observation:

  • A fatal case of ischemic brain disease is presented, stemming from cerebral atherosclerosis and a stroke during COVID-19 infection.
  • Autopsy revealed perivascular lymphocytic infiltration and vasculitis of the Vasa vasorum.
  • Thrombi were observed in the adventitial microvasculature of the Vasa vasorum.

Findings:

  • SARS-CoV-2 infection can induce inflammation and vasculitis in the Vasa vasorum.
  • This inflammation contributes to the destabilization of atherosclerotic plaques.
  • Vasa vasorum vasculitis is implicated as a mechanism for cardiovascular complications in COVID-19 patients.

Implications:

  • The Vasa vasorum plays a critical role in atherogenesis and its exacerbation during viral infections.
  • Understanding this mechanism may lead to targeted therapies for cardiovascular complications in COVID-19.
  • This research highlights the intricate relationship between viral infections and pre-existing cardiovascular conditions.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
19
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
19
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
21
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
29
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K